Targeting PANoptosis for the treatment of ischemic diseases from mechanisms to novel therapeutic strategies
Year: 2026
Type: article
Abstract: PANoptosis is a novel form of programmed cell death driven by the PANoptosome complex, which integrates key features of apoptosis, pyroptosis, and necroptosis. Existing pre-clinical research indicates that PANoptosis participates in tissue injury processes in ischemic diseases, including cerebral, myocardial, renal, retinal, and lower limb ischemia. Intervening in its core regulators reduces injury in animal models. A defining characteristic of PANoptosis is its intricate interplay with other cell death pathways, primarily mediated by shared molecular hubs such as CASP8, RIPK1, and ZBP1, which form a dynamic regulatory network. This mechanism provides new pathological dimensions for understanding ischemic injury and offers directions for exploring novel therapeutic strategies. Specifically, targeting the intersection points between PANoptosis and other death pathways enables the coordinated inhibition of multiple cell death routes, potentially overcoming the limitations of traditional single-target therapies. This review systematically summarizes the regulatory network of PANoptosis in ischemic diseases and highlights current therapeutic strategies and recent advances focused on key nodes, including upstream mitochondrial stress, PANoptosome assembly, and downstream effector molecules. Meanwhile, the limitations of current evidence and the challenges for future translation are discussed, aiming to provide theoretical references for future interventions in ischemic diseases.
Source: Cell Biology and Toxicology
Institutions: Hainan Medical University, Fudan University, Zhongshan Hospital
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: hybrid
Estimated APC paid: $4,190
Awards: 车前草提取物改善HPH肺动脉重塑的机制研究, G87840672
OpenAlex ID: W7235955156
